Literature DB >> 21624466

Interleukin 4 induces the apoptosis of mouse microglial cells by a caspase-dependent mechanism.

Javier A Soria1, Daniela S Arroyo, Emilia A Gaviglio, Maria C Rodriguez-Galan, Ji Ming Wang, Pablo Iribarren.   

Abstract

Microglial cells are resident macrophages in the central nervous system (CNS) and become activated in many pathological conditions. Activation of microglial cells results in reactive microgliosis, manifested by an increase in cell number in the affected CNS regions. The control of microgliosis may be important to prevent pathological damage to the brain. The type 2 cytokine IL-4 has been reported to be protective in brain inflammation. However, its effect on microglial cell survival was not well understood. In this study, we report a dual effect of IL-4 on the survival of mouse microglial cells. In a 6h short term culture, IL-4 reduced the death of microglial cells induced by staurosporine. In contrast, in long term treatment (more than 48h), IL-4 increased the apoptotic death of both primary mouse microglial cells and a microglial cell line N9. Mechanistic studies revealed that, in microglial cells, IL-4 increased the levels of cleaved caspase 3 and PARP, which is down-stream of activated caspase 3. In addition, IL-4 down regulated the autophagy and the antiapoptotic protein Bcl-xL in microglial cells. On the other hand, the pre-incubation of microglial cells with IL-4 for 24h, attenuated the cell death induced by the neurotoxic peptide amyloid beta 1-42 (Aβ42). Our observations demonstrate a novel function of IL-4 in regulating the survival of microglial cells, which may have important significance in reduction of undesired inflammatory responses in the CNS.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21624466      PMCID: PMC3138887          DOI: 10.1016/j.nbd.2011.05.010

Source DB:  PubMed          Journal:  Neurobiol Dis        ISSN: 0969-9961            Impact factor:   5.996


  55 in total

1.  IL-4 inhibits the expression of mouse formyl peptide receptor 2, a receptor for amyloid beta1-42, in TNF-alpha-activated microglia.

Authors:  Pablo Iribarren; Keqiang Chen; Jinyue Hu; Xia Zhang; Wanghua Gong; Ji Ming Wang
Journal:  J Immunol       Date:  2005-11-01       Impact factor: 5.422

2.  Reactive microgliosis engages distinct responses by microglial subpopulations after minor central nervous system injury.

Authors:  Martin Wirenfeldt; Alicia Anne Babcock; Rune Ladeby; Kate Lykke Lambertsen; Frederik Dagnaes-Hansen; Robert Graham Quinton Leslie; Trevor Owens; Bente Finsen
Journal:  J Neurosci Res       Date:  2005-11-15       Impact factor: 4.164

Review 3.  Autophagy fights disease through cellular self-digestion.

Authors:  Noboru Mizushima; Beth Levine; Ana Maria Cuervo; Daniel J Klionsky
Journal:  Nature       Date:  2008-02-28       Impact factor: 49.962

4.  Decreased neuronal CD200 expression in IL-4-deficient mice results in increased neuroinflammation in response to lipopolysaccharide.

Authors:  Anthony Lyons; Keith McQuillan; Brian F Deighan; Julie-Ann O'Reilly; Eric J Downer; Aine C Murphy; Melanie Watson; Alessia Piazza; Florence O'Connell; Rebecca Griffin; Kingston H G Mills; Marina A Lynch
Journal:  Brain Behav Immun       Date:  2009-06-06       Impact factor: 7.217

5.  Interleukin-13 enhances cyclooxygenase-2 expression in activated rat brain microglia: implications for death of activated microglia.

Authors:  Myung-Soon Yang; Kyung-Ae Ji; Sae-Bom Jeon; Byung-Kwan Jin; Seung U Kim; Ilo Jou; Eunhye Joe
Journal:  J Immunol       Date:  2006-07-15       Impact factor: 5.422

6.  T helper 2 cytokines inhibit autophagic control of intracellular Mycobacterium tuberculosis.

Authors:  James Harris; Sergio A De Haro; Sharon S Master; Joseph Keane; Esteban A Roberts; Monica Delgado; Vojo Deretic
Journal:  Immunity       Date:  2007-09       Impact factor: 31.745

7.  Is microglial apoptosis an early pathogenic change in cerebral X-linked adrenoleukodystrophy?

Authors:  Florian S Eichler; Jia-Qian Ren; Michael Cossoy; Anna M Rietsch; Sameer Nagpal; Ann B Moser; Matthew P Frosch; Richard M Ransohoff
Journal:  Ann Neurol       Date:  2008-06       Impact factor: 10.422

8.  CNS-derived interleukin-4 is essential for the regulation of autoimmune inflammation and induces a state of alternative activation in microglial cells.

Authors:  Eugene D Ponomarev; Katarzyna Maresz; Yanping Tan; Bonnie N Dittel
Journal:  J Neurosci       Date:  2007-10-03       Impact factor: 6.167

9.  Interleukin 10 and TNFalpha synergistically enhance the expression of the G protein-coupled formylpeptide receptor 2 in microglia.

Authors:  Pablo Iribarren; Keqiang Chen; Wanghua Gong; Edward H Cho; Stephen Lockett; Badarch Uranchimeg; Ji Ming Wang
Journal:  Neurobiol Dis       Date:  2007-05-05       Impact factor: 5.996

10.  Population control of resident and immigrant microglia by mitosis and apoptosis.

Authors:  Martin Wirenfeldt; Lasse Dissing-Olesen; Alicia Anne Babcock; Marianne Nielsen; Michael Meldgaard; Jens Zimmer; Iñigo Azcoitia; Robert Graham Quinton Leslie; Frederik Dagnaes-Hansen; Bente Finsen
Journal:  Am J Pathol       Date:  2007-06-28       Impact factor: 4.307

View more
  12 in total

Review 1.  Viral infection, inflammation and schizophrenia.

Authors:  Rachel E Kneeland; S Hossein Fatemi
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-02-10       Impact factor: 5.067

2.  Oxymatrine inhibits microglia activation via HSP60-TLR4 signaling.

Authors:  Feijia Ding; Yunhong Li; Xiaolin Hou; Rui Zhang; Shuting Hu; Yin Wang
Journal:  Biomed Rep       Date:  2016-10-11

3.  miR-155 modulates microglia-mediated immune response by down-regulating SOCS-1 and promoting cytokine and nitric oxide production.

Authors:  Ana L Cardoso; Joana R Guedes; Luís Pereira de Almeida; Maria C Pedroso de Lima
Journal:  Immunology       Date:  2012-01       Impact factor: 7.397

4.  HSP60 mediates the neuroprotective effects of curcumin by suppressing microglial activation.

Authors:  Feijia Ding; Fan Li; Yunhong Li; Xiaolin Hou; Yi Ma; Nan Zhang; Jiao Ma; Rui Zhang; Bing Lang; Hongyan Wang; Yin Wang
Journal:  Exp Ther Med       Date:  2016-06-01       Impact factor: 2.447

5.  Toll-like receptor 2 ligands promote microglial cell death by inducing autophagy.

Authors:  Daniela S Arroyo; Javier A Soria; Emilia A Gaviglio; Constanza Garcia-Keller; Liliana M Cancela; Maria C Rodriguez-Galan; Ji Ming Wang; Pablo Iribarren
Journal:  FASEB J       Date:  2012-10-16       Impact factor: 5.191

6.  Regulation of NADPH oxidase gene expression with PKA and cytokine IL-4 in neurons and microglia.

Authors:  Valentina L Savchenko
Journal:  Neurotox Res       Date:  2012-05-08       Impact factor: 3.911

7.  Autophagy down regulates pro-inflammatory mediators in BV2 microglial cells and rescues both LPS and alpha-synuclein induced neuronal cell death.

Authors:  Claudio Bussi; Javier Maria Peralta Ramos; Daniela S Arroyo; Emilia A Gaviglio; Jose Ignacio Gallea; Ji Ming Wang; Maria Soledad Celej; Pablo Iribarren
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

8.  Hippocampal expression of murine IL-4 results in exacerbation of amyloid deposition.

Authors:  Paramita Chakrabarty; Li Tianbai; Amanda Herring; Carolina Ceballos-Diaz; Pritam Das; Todd E Golde
Journal:  Mol Neurodegener       Date:  2012-07-29       Impact factor: 14.195

9.  Neuroprotective effect of resveratrol in diabetic cerebral ischemic-reperfused rats through regulation of inflammatory and apoptotic events.

Authors:  Hoda E Mohamed; Sahar E El-Swefy; Rehab A Hasan; Ahmed A Hasan
Journal:  Diabetol Metab Syndr       Date:  2014-08-17       Impact factor: 3.320

10.  Designer Cathinones N-Ethylhexedrone and Buphedrone Show Different In Vitro Neurotoxicity and Mice Behaviour Impairment.

Authors:  Cristina de Mello-Sampayo; Ana Rita Vaz; Sara C Henriques; Adelaide Fernandes; Fabiana Paradinha; Pedro Florindo; Paulo Faria; Rui Moreira; Dora Brites; Alvaro Lopes
Journal:  Neurotox Res       Date:  2020-06-13       Impact factor: 3.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.